New ICH Guideline Marks Turning Point In Supporting Multi-Regional Pediatric Development

A new high-level draft ICH guideline issued is expected to reduce the likelihood of substantial differences among regions regarding acceptance of data generated in pediatric global drug development.

More from Clinical Trials

More from R&D